REASEARCH PROJECT 2: Mycotoxin Biomarkers and Children's Health in Africa (Wild)

研究项目 2:非洲霉菌毒素生物标志物和儿童健康(野生)

基本信息

  • 批准号:
    8376301
  • 负责人:
  • 金额:
    $ 21.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-06-01 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

Child morbidity and mortality is high in sub-Saharan Africa with some 4.5 million deaths annually among children aged <5 years and 175 deaths per 1000 live births compared to 6 deaths per 1000 in industrialized nations. The majority of the childhood mortality and morbidity is due to infectious diseases, notably diarrhea, pneumonia and malaria. These problems are associated with poverty, including insufficient and poor quality food resulting in a high prevalence of malnutrition. Indeed under-nutrition and growth faltering has been identified as an underlying cause of around 50% of the deaths associated with infectious diseases in children in this region. In our previous work we found a strong association between aflatoxin biomarker levels and growth faltering in West African children; in addition, there was evidence of altered immunity in individuals with high biomarker levels. Dietary exposure to this mycotoxin may therefore make a significant contribution to childhood morbidity and mortality. The first goal of this project is to characterize the contribution of mycotoxin exposure early in life (pre- and post-natal) to growth faltering and health outcomes. We will test for an association between biomarkers of aflatoxin exposure and intestinal permeability as a first test of whether aflatoxin may affect growth via this mechanism. Maize is the main dietary staple for over 50% of the population in West Africa and is frequently co-contaminated with aflatoxins and another class of mycotoxins, the fumonisins. A second project goal is therefore to validate fumonisin exposure biomarkers to permit an evaluation of the combined effects of aflatoxins and fumonisins on child growth. Finally we will conduct postharvest intervention studies on maize using low technology approaches to assess their effectiveness in reducing human exposure to these environmental toxins, including via maize-based weaning foods that contribute much to the mycotoxin burden in young children. Collectively these studies will collaboratively link with biomarker research in Project 1 and lay the groundwork for application of targeted chemoprevention strategies described in Project 4.
撒哈拉以南非洲的儿童发病率和死亡率很高, 5岁以下儿童和每1 000名活产死亡175人,而工业化国家每1 000名活产死亡6人。 nations.大多数儿童死亡和发病是由于传染病,特别是腹泻, 肺炎和疟疾。这些问题与贫困有关,包括数量不足和质量差 粮食短缺导致营养不良率很高。事实上,营养不足和增长步履蹒跚一直是 被确定为约50%与传染病有关的儿童死亡的根本原因 在这个地区。在我们之前的工作中,我们发现黄曲霉毒素生物标志物水平与 西非儿童的生长迟缓;此外,有证据表明, 生物标志物水平很高因此,从饮食中接触这种真菌毒素可能会对 儿童发病率和死亡率。该项目的第一个目标是描述 霉菌毒素暴露在生命早期(产前和产后),以生长蹒跚和健康结果。我们将测试 黄曲霉毒素暴露的生物标志物和肠道通透性之间的关联,作为是否 黄曲霉毒素可通过这种机制影响生长。玉米是超过50%的美国人的主要主食。 在西非的人群中,经常受到黄曲霉毒素和另一类真菌毒素的共同污染, 伏马菌素因此,第二个项目目标是验证伏马菌素暴露生物标志物, 评价黄曲霉毒素和伏马菌素对儿童生长的联合作用。最后,我们将进行采后 采用低技术方法对玉米进行干预研究, 减少人类接触这些环境毒素,包括通过玉米为基础的断奶食品, 对幼儿的霉菌毒素负担有很大影响。总的来说,这些研究将相互联系 与项目1中的生物标志物研究相结合,为靶向化学预防的应用奠定基础 项目4中描述的策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTOPHER P WILD其他文献

CHRISTOPHER P WILD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTOPHER P WILD', 18)}}的其他基金

REASEARCH PROJECT 2: Mycotoxin Biomarkers and Children's Health in Africa (Wild)
研究项目 2:非洲霉菌毒素生物标志物和儿童健康(野生)
  • 批准号:
    7515860
  • 财政年份:
    2008
  • 资助金额:
    $ 21.19万
  • 项目类别:
REASEARCH PROJECT 2: Mycotoxin Biomarkers and Children's Health in Africa (Wild)
研究项目 2:非洲霉菌毒素生物标志物和儿童健康(野生)
  • 批准号:
    8278589
  • 财政年份:
  • 资助金额:
    $ 21.19万
  • 项目类别:
REASEARCH PROJECT 2: Mycotoxin Biomarkers and Children's Health in Africa (Wild)
研究项目 2:非洲霉菌毒素生物标志物和儿童健康(野生)
  • 批准号:
    7849772
  • 财政年份:
  • 资助金额:
    $ 21.19万
  • 项目类别:
REASEARCH PROJECT 2: Mycotoxin Biomarkers and Children's Health in Africa (Wild)
研究项目 2:非洲霉菌毒素生物标志物和儿童健康(野生)
  • 批准号:
    8078951
  • 财政年份:
  • 资助金额:
    $ 21.19万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了